Arman Qamar MD MPH

Interventional Cardiology l Vascular Medicine l Clinical Research I NorthShore University Health System

[Arman Qamar MD MPH @AqamarMD]

A biomarker risk score approach identifies patients deriving highest absolute benefit from intensive LDL lowering with ezetimibe. @TIMIStudyGroup @rgiugliano @califf001 @cpcannon #EugeneBraunwald #DavidMorrow #IMPROVEIT @precisionfda @HarvardChanSPH https://t.co/U3sSLzAJe5

[Aman Goyal @AmanGoyalMD]

Read our latest contemporary review on polygenic risk in venous thromboembolism. Polygenic risk score improves risk prediction, guides anticoagulant use, and helps tailor prevention.

@AqamarMD @MananPareekMD @KMAlexanderMD

Link: https://t.co/yFuUqoQu3r

[Hemostasis Today @HemostasisToday]

We are Routinely Evaluating VTE PRS in the Clinic in Many of Our Patients With Unprovoked VTE - @AqamarMD
@RPTHjournal
@AJTafur

https://t.co/USSRgwkU2h

#Health #Hematology #Hemostasis #MedED #MedX #HemostasisToday #VTERiskPrediction #Medicine #PolygenicRiskScore #PRS #RPTHJournal #VTEPRS

[Arman Qamar MD MPH @AqamarMD]

@Abdul_Qadeer_MD @pruthap287 @drshehryar007 Great work !

[Abdul Qadeer, MD @Abdul_Qadeer_MD]

Wrapped up an amazing week at #SCAI2025 in Washington, DC! Huge thanks to the incredible mentor, Dr. Arman Qamar for the inspiration and guidance and my research team at MCA and HVRA.

[Arman Qamar MD MPH @AqamarMD]

@HarshGMD @AvinainderSingh @ShahzebKhanMD @EndeavorHlth

[Arman Qamar MD MPH @AqamarMD]

Exciting opportunity! We’re looking for a Cardiovascular Outcomes Research Fellow to join our team at Endeavor Health. If you’re passionate about advancing CV research & making a real impact, apply now! DM for more details. #Hiring @mj_ricciardi @HeartOTXHeartMD @SripalBangalore

[Arman Qamar MD MPH @AqamarMD]

Exciting opportunity! We’re looking for a Cardiovascular Outcomes Research Fellow to join our team at Endeavor Health. If you’re passionate about advancing CV research & making a real impact, apply now! DM for more details. #Hiring @mj_ricciardi @HeartOTXHeartMD @SripalBangalore

[Arman Qamar MD MPH @AqamarMD]

Thanks to many who attended our CVI Personalized Medicine Symposium: https://t.co/pqUJoszHXL @EndeavorHlth @amitvkhera @GenomicMD @EndeavorHlth

[Arman Qamar MD MPH @AqamarMD]

Great discussing ORBITA-STAR: ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI https://t.co/34XfsdcWcX @EndeavorHlth @HeartOTXHeartMD @mj_ricciardi

[Zainali Chunawala @zainchunawala]

Our new work in #Atherosclerosis @ATHjournal studying the association of PAD, CKD and recurrent admissions for ADHF.

Special thank you to @CaugheyPhD for her great mentorship!

https://t.co/fBAUGrs2lY

[Atherosclerosis @ATHjournal]

Among patients hospitalized w/ ADHF, those w/ concurrent PAD have more prevalent 🫀 comorbidities and higher likelihood of 1-y ADHF readmission, irrespective of CKD status
🔗https://t.co/dOwp3lbHDn
@zainchunawala @DLBHATTMD @AqamarMD @mvaduganathan @robmentz @JLGrodin @CaugheyPhD

[James Horowitz @jameshorowitzmd]

@agtruesdell @ShashankSinhaMD @SCAI @BurkhoffMd @dranulala @JasonKatzMD @OrenFriedman @FMaeWestMD @IM_Crit_ @ERC_resus @BenjaminAbella @glennfishman @CardsNYC @SripalBangalore @carlosalviar @bhwords @GBarnesMD @DrDrewKleinPHI @mdonnino @VTEIreland 🔥The #FlowTriever Arm primary endpoint was compared to a performance goal of 32%, based on a published meta-analysis

The magnitude of the benefit was so large in #FLAME that investigators stopped the study early to share these outcomes at #ACC23 earlier this year

[Arman Qamar MD MPH @AqamarMD]

@jpirruccello @TCTMD_Yael @HeartOTXHeartMD @mj_ricciardi @NorthShoreWeb Agree James, long term dapt with ticag 60 beyond 1 year is reasonable approach.

[Arman Qamar MD MPH @AqamarMD]

Great summary on antiplatelet therapy for 2nd-prevention @TCTMD_Yael @HeartOTXHeartMD @mj_ricciardi @NorthShoreWeb

[Yael L. Maxwell @TCTMD_Yael]

For some 2nd-prevention patients, clopidogrel seems to be superior to aspirin monotherapy after PCI regardless of baseline clinical risk or relative ischemic and bleeding risks, says a post hoc analysis of HOST-EXAM

https://t.co/1qOleUo2T9 @aqamarmd

[Arman Qamar MD MPH @AqamarMD]

@mj_ricciardi @TCTMD_Yael @HeartOTXHeartMD @NorthShoreWeb @TCTMD Thanks Mark!

[Mark J Ricciardi MD @mj_ricciardi]

@AqamarMD @TCTMD_Yael @HeartOTXHeartMD @NorthShoreWeb @NorthShoreWeb we’ve become accustomed to @AqamarMD brilliant insights for all things antiplt and anticoag. Nice to see these expert’s views on @TCTMD 💪

[John P Erwin III MD MBA MACC (#BigPoppy ) @HeartOTXHeartMD]

Great #CardioTwitter research showcase @NorthShoreWeb IMED #GrandRounds this morning w @mj_ricciardi , @AqamarMD , and David Davidson.

Great team we have here!

[Arman Qamar MD MPH @AqamarMD]

@docmohitgupta @durgeshjhaTOI @smittal_ips @DLBHATTMD @mmamas1973 @ICMRDELHI Great work @docmohitgupta

[Mohit D Gupta DM, FACC, FESC, FSCAI @docmohitgupta]

Landmark Analysis: Covid 19 Vaccination in India ( covishield and covaxin) doesn’t lead to more heart attack & has protective effect on patients of heart attack. Plos-One 2023. More than 1500 patients. @durgeshjhaTOI @smittal_ips @DLBHATTMD @AqamarMD”@mmamas1973 @ICMRDELHI

[Sarah Hudson @sarahhudsonuk]

Ten current papers for the curious general cardiologist, including ticagrelor monotherapy post PCI, MRA use in cardiac amyloid, asystole post shock from wearable defibs & ⬇️in mortality using telemonitoring in HF

Sources: @ESC_Journals, @JACCJournals, @JAMACardio

1/n

[Arman Qamar MD MPH @AqamarMD]

@BharatRawlley @UpstateNews @InnovateUpstate @UpstateIM_Res @UpstateCardiol1 @UCMSofficial @krtkgpt @HFHCardioFellow @ACordova92 @uvmcards @KannuBansalMD @BIDMCNeuroRes @harvardmed @AnkurKalraMD @UtkarshDayal @i_salooja @DhawaniJ @hvanspall @ErinMichos @ShahzebKhanMD @SameerAroraMD Great work! Congratulations